We’ve just witnessed a historical moment for the ever-growing marijuana market…
The U.S. House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act with a vote of 228 to 164 last Friday (Dec. 4).
If the bill were to be fully approved, it would essentially decriminalize marijuana on a federal level.
While this is largely seen as a symbolic gesture, as the bill is poised to be shot down in the Senate, this is the first time ever that Congress has voted on the matter.
And it’s a major step in cannabis’ path to legality…
That’s because it shows that awareness surrounding the injustices of non-violent marijuana convictions, as well as the herb’s medicinal benefits, continues to grow.
This means the stigma around cannabis is also slowly dissipating. CNBC reported a Gallup Poll showing 68% of Americans now support the legalization of marijuana. That’s the highest level of support ever recorded for the industry.
This support will likely continue…
You see, cannabis is already legal in a large majority of states. Nearly one-third of all Americans live in a state with legalized recreational cannabis.
Meanwhile, 34 states offer people the ability to seek medical marijuana permits. And even if the bill ultimately flops, it’ll force more states to re-evaluate their existing cannabis rules and regulations…
That’s exactly why I’m bringing you a cannabis stock that’s not only continuing to rapidly grow but is also one of the few profitable marijuana companies around…
Buy This Profitable Cannabis Company Now
Trulieve Cannabis Corp. (OTCMKTS: TCNNF) is a multi-state marijuana company that has proven itself in the emerging cannabis space.
Unlike other up-and-coming companies in the industry, Trulieve is extremely profitable given its size.
In fact, in November, the cannabis company reported earnings before interest, taxes, depreciation, and amortization (EBITDA) were $67.5 million versus the anticipated EBITDA of $61.5 million.
Meanwhile, Trulieve’s revenue in the third quarter grew by 13% to $136 million.
Part of this is due to its ever-expanding footprint in the Pennsylvania marijuana market. In the third quarter, the company bought marijuana companies PurePenn and Solevo Wellness.
Currently, Pennsylvania is estimated to achieve sales of $261 million this year. By 2025, market research firm Statista says sales will surge to $1.25 billion. So, these acquisitions will enable Trulieve to take advantage of the massive opportunities within the state.
However, what makes Trulieve truly compelling as a marijuana stock is its dominance of the Florida market…
You see, it has 64 retail stores in the state, allowing for it to account for half of Florida’s medical marijuana market share…
Right now, Florida’s total cannabis market is valued at $727 million. By 2025, Statista highlighted the state’s sales will be around $2.5 billion.
This has clearly paid off for the company already. Trulieve’s shares have surged 125% year-to-date to $29.46 per share.
But that doesn’t mean there isn’t room for even greater growth ahead.
As the U.S. continues to make strides towards broader marijuana legalization and Trulieve maintains its expansion momentum, the company’s shares will likely soar higher as well.
You NEED to See This Photo…
Take a look at this photo, shot by the Mayo Clinic’s most elite researchers:
These two elderly mice are exactly the same age.
But as you can see…
The one on the left is graying and frail, as you’d expect an elderly mouse to be…
And the mouse on the right is strong, healthy, and showing none of the symptoms of aging.
How can this be possible?
The answer is simple:
Because of the groundbreaking new technology contained within this pill…
Which is undergoing human trials as we speak.
As you will see in this special presentation…
We’re about to witness the biggest medical breakthrough in history…
In fact, I believe that investors who set themselves up to profit from it could turn every $500 invested into as much as $1.5 million.
